Showing results (81-90 of 87) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
JCO Precision Oncology|June 27, 2024
Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (DPYD) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer CenterD Grace Nguyen, Sarah A Morris, Alicia Hamilton, et al.The Journal of Clinical Investigation|August 16, 2016
Tumor immune profiling predicts response to anti-PD-1 therapy in human melanomaAdil I Daud, Kimberly Loo, Mariela L Pauli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301Antonius A Miller, Daryl J Murry, Kouros Owzar, et al.BJC Reports|November 8, 2024
Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of responseZoe Quandt, Saya Jacob, Muhammad Zaki Hidayatullah Fadlullah, et al.Research Square|July 10, 2026
Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancerHeinz Lenz, Hiroyuki Arai, Andrew Elliott, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2024
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyTimothy L Cannon, Michael Rothe, Pam K Mangat, et al.Cancer Immunology Research|April 16, 2017
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLCPaul C Tumeh, Matthew D Hellmann, Omid Hamid, et al.Pageof 9